share_log

HC Wainwright & Co. Reiterates Buy on ImmunoPrecise Antibodies, Maintains $9 Price Target

HC Wainwright & Co. Reiterates Buy on ImmunoPrecise Antibodies, Maintains $9 Price Target

HC Wainwright & Co.重申買入ImmunoPrecise抗體,維持9美元的目標股價
Benzinga ·  03/15 21:24

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ImmunoPrecise Antibodies (NASDAQ:IPA) with a Buy and maintains $9 price target.

HC Wainwright & Co. 分析師Swayampakula Ramakanth重申了ImmunoPrecise Antibodies(納斯達克股票代碼:IPA)的買入並維持9美元的目標股價。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論